180 Life Sciences Corp (NASDAQ: ATNF) is -42.07% lower on its value in year-to-date trading and has touched a low of $1.31 and a high of $21.28 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ATNF stock was last observed hovering at around $2.91 in the last trading session, with the day’s loss setting it -0.56%.
Currently trading at $2.35, the stock is 43.03% and 34.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.28 million and changing -19.24% at the moment leaves the stock -46.11% off its SMA200. ATNF registered -88.65% loss for a year compared to 6-month loss of -37.75%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 45.06% gain in the last 1 month and extending the period to 3 months gives it a 1.29%, and is 42.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 51.90% over the week and 20.89% over the month.
180 Life Sciences Corp (ATNF) has around 4 employees, a market worth around $1.25M and $0.00M in sales. Distance from 52-week low is 79.39% and -88.96% from its 52-week high.
The shares outstanding are 0.53M, and float is at 0.52M with Short Float at 6.84%.
180 Life Sciences Corp (ATNF) Insider Activity
The most recent transaction is an insider purchase by Woody James N., the company’s Chief Executive Officer. SEC filings show that Woody James N. bought 25,000 shares of the company’s common stock on Dec 15 ’23 at a price of $0.19 per share for a total of $4700.0. Following the purchase, the insider now owns 66888.0 shares.
180 Life Sciences Corp disclosed in a document filed with the SEC on Dec 15 ’23 that Feldmann Marc (Director) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Dec 15 ’23 and was made at $0.19 per share for $4700.0. Following the transaction, the insider now directly holds 0.12 million shares of the ATNF stock.
